XTX Topco’s VolitionRx VNRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.12K Buy
35,347
+9,966
+39% +$6.74K ﹤0.01% 3825
2026
Q2
$34.3K Buy
25,381
+23,078
+1,002% +$55.7K ﹤0.01% 3797
2026
Q1
$9.3K Buy
+2,303
New +$11K ﹤0.01% 3701
2025
Q4
– Sell
-1,784
Closed -$24.2K – 3854
2025
Q3
$24.2K Buy
+1,784
New +$23.7K ﹤0.01% 2293
2025
Q2
– Sell
-1,614
Closed -$18.4K – 3231
2025
Q1
$18.4K Buy
1,614
+546
+51% +$6.51K ﹤0.01% 2155
2024
Q4
$12.8K Buy
+1,068
New +$14.3K ﹤0.01% 2114

Other funds holding VNRX

XTX Topco's VNRX Position: Q3 2026 in Review

XTX Topco increased its VolitionRx (VNRX) stake by 39% in Q3 2026, buying an estimated $6.74K and bringing the position to 35,347 shares worth $9.12K. The position accounts for ﹤0.01% of the portfolio, ranked #3825.

XTX Topco first reported a position in VNRX in Q4 2024 and has held it in 6 quarters since. The position peaked at $34.3K in Q2 2026. 28 funds tracked by Wall St. Rank hold VNRX as of Q3 2026.

  • XTX Topco held 35,347 shares of VolitionRx worth $9.12K as of Q3 2026.
  • XTX Topco bought 9,966 VolitionRx shares in Q3 2026, an estimated $6.74K.
  • VolitionRx made up ﹤0.01% of XTX Topco's portfolio in Q3 2026, its #3825 holding.
  • XTX Topco first reported a position in VolitionRx in Q4 2024 and has held it in 6 quarters since.
  • XTX Topco's VolitionRx position peaked at $34.3K in Q2 2026.
  • 28 funds tracked by Wall St. Rank held VolitionRx as of Q3 2026.

Based on XTX Topco's 13F filing for Q3 2026, filed 16 Nov 2026.